FDA warning letter · Drugs

Curia New York, Inc.

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to have laboratory control records that include complete data derived from all laboratory tests conducted to ensure your API and intermediates comply with established specifications and standards.

Passage 2

Failure of your quality unit to exercise its responsibility to ensure the API and intermediates manufactured at your facility are in compliance with CGMP.

Passage 3

Failure to exercise sufficient controls over computerized systems to prevent unauthorized access or changes to data.